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a b s t r a c t
Coronary CT angiography (coronary CTA) represents an increasingly applied noninvasive
method for coronary artery imaging. Due to technical development and improved spatial
and temporal resolution of CT, high diagnostic value of coronary CTA is reported when
compared to conventional selective angiography. The aim of this review is to present an
overview of the clinical applications of coronary CTA. Important factors in patient selection
and preparation are also brieﬂy discussed.
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Coronary artery disease (CAD) is the leading cause of morbidity
and mortality in developed countries [1]. Invasive selective
coronary angiography was the only method to image coronary
arteries for a long time and is still the gold standard [2].
However, technology allowing nonivasive imaging by coronary
CT angiography (coronary CTA) has progressed remarkably
during the last three decades. Harrel and his research group
laid the groundwork for cardiac CT already in 1976 and 1979 [3].
The basic principles of their reconstruction technique and
particularly their method of obtaining a short snapshot of the
heart are still applied today in what is now known as
multisegment reconstruction [3]. It took more than two
decades of research after Harrel's initial experiment to develop
CT scanners suitable for routine cardiac imaging. The
introduction of 16-slice CT in 2003 and 64-slice CT in 2004
marked the arrival of technology with sufﬁcient spatial and
temporal resolution for assessment of coronary arteries [4].
Today, only ≥64-slice CT is considered to be appropriate for
coronary artery imaging.
Basic aspects of image acquisition
Coronary CTA has some speciﬁc technical aspects which need
to be brieﬂy addressed. CT imaging of the heart requires
minimization of cardiac motion artifacts. For this reason,
coronary CTA scanning is performed with simultaneous ECG
registration. Two basic methods are recognized: prospective
triggering and retrospective gating. Prospective ECG triggering
is a method in which the data are acquired at a pre-speciﬁed
phase of the cardiac cycle. For coronary CTA, the phase with
minimal heart motion and therefore minimal coronary artery
motion (usually in mid-diastole or in end-systole in patients
with an accelerated heart rate) is selected. In retrospective ECG
gating, data are acquired throughout the entire cardiac cycle,
and only the data obtained during the cardiac phase with the
least motion artifacts are used for image reconstruction. The
protocol for cardiac CT is highly dependent on the technology
delivered by each vendor. Some vendors attempt to decrease
the radiation dose by prospective triggering and fast rotation
times, while others build their protocols mainly on helical
scanning and ECG pulsing, where full dose images are acquired
only during a pre-selected phase. Prospective ECG triggering is
being performed more frequently in recent years because of its
relatively low radiation dose (2–6 mSv) in comparison with theretrospective gating or pulsing methods (6–20 mSv). However,
the most important disadvantage of prospective triggering lies
in the fact that images can be reconstructed only for a pre-
selected phase of the cardiac cycle, and functional assessment
of the heart (e.g. assessment of left ventricular ejection
fraction) is thus not feasible. All coronary CTAs are contrast
examinations. Image quality depends on the contrast-to-noise
ratio, and therefore high concentration iodine (e.g. 350 mg/ml
or 400 mg/ml) contrast agents are preferred. Contrast volume
ranges from 50 to 100 ml. The required injection rate is
typically between 4 and 7 ml/s and so adequate intravascular
access (20 gauge or 18 gauge intravenous cannula placed
typically in the right antecubital vein is usually used) is
needed. Optimal images require high intra-arterial opaciﬁca-
tion of more than 250 Hounsﬁeld units (HU). Vascular
enhancement should be maintained for the duration of data
acquisition; therefore accurate timing of the scan is necessary.
For this purpose, either the bolus tracking or the test bolus
technique can be used. The bolus tracking technique is based
on automatic scan triggering. In this strategy, the region of
interest (left atrium, ascending or descending aorta) is selected
and is sampled every 1–2 s after the initiation of contrast agent
administration. When the density in the selected region
exceeds target density value (e.g. 100 HU), scanning is started.
In the test bolus strategy, a small test bolus is administered,
and sampling is performed at the region of interest every 1–2 s,
allowing measurement of the time to contrast arrival. This
time is then used to trigger the scan acquisition once the full
contrast dose has been administered.
Patient preparation
The following set of recommendations is usually given to the
patient undergoing coronary CTA [5]: (1) no food intake for 4 h
before the examination; (2) drinking of water or clear ﬂuids up
until time of the examination is not restricted and is even
encouraged, mainly to improve hydration of the patient in
order to prevent renal impairment caused by contrast agent
administration and also for the ease of establishing venous
access; (3) caffeine products should be restricted 12 h before
examination, as they might hinder efforts to reduce the heart
rate before scanning; (4) regular blood pressure medication,
particularly heart rate lowering drugs, should not be discon-
tinued prior examination; (5) pre-medication for contrast
allergy as prescribed by the referring physician; (6) metformin
discontinuation for 48 h after examination is usually advised
although this recommendation seems to be nowadays rather
Table 1 – Appropriate indications for coronary CTA
according to the recommendations of the Society of
Cardiovascular Computed Tomography [7].
1) Detection of CAD in symptomatic patients without known
ischemic heart disease
A) Patients with nonacute presentation and symptoms possibly
representing an ischemic equivalent
- low pretest probability of CAD and ECG uninterpretable or
unable to exercise
- intermediate pretest probability of CAD and ECG interpretable
and able to exercise
- intermediate pretest probability of CAD and ECG
uninterpretable or unable to exercise
- normal ECG exercise test and continued symptoms
- discordant ECG exercise test and imaging results
- equivocal stress imaging results
B) Patients with acute presentation and suspicion of ACS
- low pretest probability of CAD and normal ECG and cardiac
biomarkers
- low pretest probability of CAD and nondiagnostic ECG or
equivocal cardiac biomarkers
- low pretest probability of CAD and ECG uninterpretable
- intermediate pretest probability of CAD and normal ECG and
cardiac biomarkers
- intermediate pretest probability of CAD and nondiagnostic ECG
or equivocal cardiac biomarkers
- intermediate pretest probability of CAD and ECG
uninterpretable
2) Detection of CAD in patients with new-onset or newly
diagnosed HF and no prior CAD
- low or intermediate probability of CAD and reduced left
ventricular ejection fraction
3) Detection of CAD in patients undergoing noncoronary cardiac
surgery
- intermediate pretest probability of CAD
4) Risk assessment after CABG
- evaluation of graft patency in patients with symptoms possibly
representing ischemic equivalent
- localization of graft prior to reoperative chest or cardiac surgery
5) Risk assessment after PCI in asymptomatic patients
- prior left main PCI with stent diameter ≥3 mm
6) Assessment of anomalies of coronary arteries
CAD, coronary artery disease; HF, heart failure; PCI, percutaneous
coronary intervention; CABG, coronary artery bypass grafting.
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controlling drugs like beta blockers and other drugs with
negative chronotropic properties, such as ivabradine [6] and
verapamil, are administered in order to achieve a target heart
rate of 50–60 beats/min to minimize motion artifacts (at our
institution 50–300 mg of short-acting esmolol is administered
intravenously immediately prior to scanning); (8) sublingual
administration of nitrates a few minutes before the initiation
of the scan protocol is recommended in patients without
contraindication, in order to improve visualization of the
coronary arteries.
Patient selection
Appropriate selection of patients who should beneﬁt from
coronary CTA is of utmost importance. The list of indications
that are currently considered to be appropriate according to
the recommendations of the Society of Cardiovascular
Computed Tomography and other expert societies [7] is shown
in Table 1. However, not all patients with an appropriate
clinical indication are suitable for coronary CTA. It is
mandatory that patients undergoing coronary CTA are able
to cooperate with instructions to be motionless, supine, and to
hold their breath during the imaging [8]. Subjects with a rapid
heart rate (≥100 beats/min), particularly with irregular R–R
intervals such as in atrial ﬁbrillation, are also not suitable
candidates for coronary CTA. Until recently, irregular heart
rates >80 beats/min represented a relative contraindication
for coronary CTA because of the high incidence of motion
artifacts [4]. However, ongoing hardware and software
development and improvements, such as ≥64-slice CT,
wide-detector scanners, or dual-source CT, now allow the
scanning of patients with higher and irregular heart rates with
sufﬁcient imaging quality. Therefore, the decision, whether
the examination of the patient with higher heart rate will be
performed, depends not just only on the patient's heart rate
but also on the available CT equipment. Moreover, patients
with a higher heart rate or signiﬁcant heart rate variability (e.g.
>5 beats/min) are not well-suited for a prospectively ECG-
triggered technique and thus often require a retrospective ECG
gating method with a signiﬁcantly higher radiation dose [9].
Coronary CT in clinical applications
Suspected stable coronary artery disease
The most obvious indication for cardiac CT is to exclude CAD
in patients with symptoms possibly representing an ischemic
equivalent with low-to-intermediate pretest probability of
CAD. Other clinical scenarios include patients with low-to-
intermediate pretest probability of CAD and new-onset or
newly diagnosed heart failure with reduced left ventricular
ejection fraction, as well as subjects undergoing noncoronary
cardiac surgery with intermediate pretest probability of CAD.
Numerous single and multicenter studies have addressed the
diagnostic value of coronary CTA in detecting stenoses of
coronary arteries [10–12]. Based on the results of so far
published studies particularly very good negative predictivevalue was highlighted (Fig. 1). In very recent meta-analysis
performed by Menke and Kowalski including 30 studies (3422
patients) published between 2005 and 2013, diagnostic
performance of coronary CTA was assessed and the ﬁndings
were compared with invasive selective coronary angiography
representing the gold standard in imaging of coronary arteries
[13]. Most studies (22 studies with 2593 patients) in this meta-
analysis applied ≥64-slice CT or dual-source CT. About 6% of
coronary CTA examinations were unevaluable. Even consid-
ering unevaluable results, the pooled sensitivity of coronary
CTA was 93.9% and speciﬁcity 79.2%. Sensitivity and speciﬁcity
were even higher in the subgroup of patients examined by ≥64-
slice CT (95.6% and 81.5%).
On the other hand, patients with high pretest likelihood of
CAD (e.g. older men or women with typical angina pectoris)
should not undergo coronary CTA for exclusion of CAD as the
ﬁrst-line imaging method, because more patients in this
subgroup would require invasive selective coronarography as
Fig. 1 – Three-dimensional volume-rendered CT image
depicting normal coronary arteries.
Fig. 2 – Large noncalcified plaque in the proximal left
anterior descending coronary artery is shown on coronary
CT angiography.
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thus negative coronary CTA results are less reliable.
Suspected acute coronary syndrome
Coronary CTA represents an alternative to conventional
selective angiography in patients with suspected acute
coronary syndrome (ACS), who have low or intermediate
pretest probability of CAD and their ECG is either normal or
non-diagnostic, and cardiac biomarkers are normal or equivo-
cal. Four randomized trials, CT-STAT [14], ACRIN-PA [15],
ROMICAT II [16] and CT-COMPARE [17], have compared a
strategy based on coronary CTA to the standard of care in
evaluation of over 3000 patients with suspected ACS with low-
to-intermediate risk. These trials consistently demonstrated
the safety of negative coronary CTA results in identifying
patients for discharge from the emergency department with
very low rates (<1%) of major adverse cardiovascular events, at
signiﬁcantly lower cost, and greater efﬁciency in terms of time
to discharge and length of hospital stay [18].
Coronary plaques
Atherosclerotic plaques start accumulating long before the
development of luminal stenoses and the early stages of
coronary plaques are typically associated with the outer
expansion of the wall (positive remodeling of the vessel) [19].
Even this early stage of atherosclerosis is known to be
associated with increased risk of the cardiovascular events.
Because coronary CTA has the ability to simultaneously assess
luminal dimensions and the vessel wall, it can detect these
early disease stages, which are not well visualized by invasive
coronary angiography. In coronary CTA examination, plaquesare usually classiﬁed according to the presence or absence of
calciﬁed components, thereby differentiating between calci-
ﬁed, partially calciﬁed (mixed), and non-calciﬁed plaques [20]
(Fig. 2). However, subclassiﬁcation of non-calciﬁed plaques to
lipid-rich and ﬁbrous lesions based on the values of CT
attenuation cannot be easily applied. Although the density of
plaques measured by CT correlates with echogenicity deter-
mined by intravascular ultrasound, there is signiﬁcant overlap
of attenuation values between the different non-calciﬁed
plaques types. Despite the challenges associated with classiﬁ-
cation of plaques based on CT attenuation, there is evidence
that low density plaques (<30 HU) are more often seen in
patients with ACS than those with stable CAD, and that these
plaques are more often associated with a ruptured ﬁbrous cap
of the culprit lesion [21]. The effect of calciﬁcation on plaque
instability is controversial. While heavily calciﬁed plaques are
relatively stable, plaques containing small (<1 mm) spotty
calciﬁcations are associated with accelerated disease progres-
sion and are one of the features of vulnerable plaques [22].
Moreover, the napkin-ring sign is considered to be a speciﬁc CT
feature of plaques with large necrotic core and thus represents
a reliable marker of plaque instability. The napkin-ring sign is
a qualitative plaque feature which can be deﬁned in a non-
calciﬁed plaque cross-section by the presence of two features:
a central area of low CT attenuation that is apparently in
contact with the lumen and a ring-like higher attenuation
plaque tissue surrounding this central area [20].
Coronary anomalies
The prevalence of coronary anomalies varies widely depend-
ing on the literature source. Anomalies of origin, course and
termination can be distinguished [23]. From the clinical
perspective anomalous origin of the right or left coronary
artery from an inappropriate sinus is of clinical importance
(Fig. 3). The prevalence of this pathology is approximately 1%
Fig. 3 – Three-dimensional volume-rendered CT image showing an interarterial course of the right coronary artery originating
from the left sinus of Valsalva.
Fig. 4 – Three-dimensional volume-rendered CT image
depicting normal left internal mammary bypass graft to the
left anterior descending coronary artery (marked with
arrow), as well as a normal venous bypass graft to the
obtuse marginal artery.
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increased risk of sudden cardiac death when the coronary
artery has an interarterial course between the aorta and
pulmonary artery. The major advantage of coronary CTA in the
diagnostic workup of a suspected coronary anomaly is better
anatomic depiction of the origin and course of the coronary
artery. Coronary CTA is either performed as a ﬁrst line method
or after conventional selective coronarography either because
the latter could not detect a coronary artery or because the
course of the anomalous coronary artery was not clear from
the invasive coronary angiography.
Coronary artery bypass grafts (CABG)
In patients who underwent surgical revascularization of the
myocardium, recurrence of symptoms can be due to graft
stenosis or occlusion, or due to progression of atherosclerosis
in the native vessels. In general, imaging of venous grafts is
less challenging than imaging of the native coronary arteries
because they are usually of larger size and have reduced
mobility. Assessment of internal mammary artery grafts can
be more difﬁcult due to artifacts caused by metal clips and
because of their smaller diameter. Evaluation of the distal graft
anastomosis is sometimes challenging due to the frequent
presence of calciﬁcations or clips at the site and due to greater
motion of this portion of the graft. Nevertheless, diagnostic
performance in detecting graft stenosis or occlusion is usually
excellent with sensitivity and speciﬁcity exceeding 95% [25]
(Fig. 4). However, the investigation of the native coronary
arteries is often very difﬁcult because of pronounced athero-
sclerotic involvement and especially because of severe
calciﬁcations. Therefore, the diagnostic yield of coronary
CTA in assessment of native coronary vessels in this subgroup
of patients is frequently decreased and the number of
unevaluable segment is relatively high.Coronary artery stents
In most patients with signiﬁcant CAD, percutaneous coronary
intervention comprises placement of a stent rather than
angioplasty alone (Fig. 5). The evaluation of stents is more
challenging than the assessment of native coronary arteries.
Several types of artifacts can complicate the evaluation of
Fig. 5 – Curved multiplanar reformation demonstrating
stent without restenosis in the left anterior descending
artery.
Fig. 6 – Decreased attenuation in the subendocardial layer of
the inferior wall corresponding to prior myocardial
infarction.
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CT density along the stent and black streaks may occur in the
vessel lumen; partial volume artifact can be associated with a
loss of the sharp edge delineating the stent and the lumen).
Overall, the diagnostic accuracy is better in stents with diameter
≥3 mm [26]. When coronary CTA was used to evaluate in-stent
restenosis using intravascular ultrasound as the reference
standard, the sensitivity was 67% and speciﬁcity 78% for stents
with diameter <3 mm, whereas for stents with diameter ≥3 mm
it was 89% and 100%. Moreover, the diagnostic performance of
coronary CTA has been found to be superior in stents with
thinner struts (<100 mm) compared to stents with thicker struts
[27]. Because of the limitations of coronary CTA only evaluation
of stents in left main coronary artery in asymptomatic
individuals is considered clearly appropriate.
Contemporary directions
Coronary CTA tends to overestimate stenoses in patients with
CAD and lacks functional information about the hemodynam-
ic signiﬁcance of borderline stenoses. Thus, a combined
anatomic and functional assessment of CAD seems to be of
great importance. This can be achieved by combination of
coronary CTA with myocardial CT perfusion (myocardial CTP)
(Fig. 6) or with fractional ﬂow reserve-CT (FFR-CT).
Stress myocardial CTP is based on evaluation of myocardial
attenuation after application of coronary vasodilatating drugs
like adenosine, dypiridamole, or regadenoson. Very recently, a
large multicenter, prospective study exploring the accuracy of
combined coronary CTA and myocardial CTP in the detection
of ﬂow-limiting stenoses (as assessed by the combination of
invasive coronary angiography and single photon emission CT
representing the reference methods) was published [28]. In a
per-patient analysis, the accuracy of coronary CTA alone
was 69% compared to 75% for the combination of coronaryCTA and myocardial CTP, while in a per-vessel analysis, the
accuracy of coronary CTA alone was 73%, and increased to 79%
when combination of coronary CTA and myocardial CTP was
applied.
FFR-CT is a novel technology that enables determination of
the functional signiﬁcance of lesions noninvasively, using
sophisticated computer algorithms based on computational
ﬂuid dynamics applied to coronary CTA [29]. There is evidence
from several randomized studies, comparing FFR-CT with
invasive FFR (representing the gold standard), that FFR-CT can
be helpful in evaluation of hemodynamic signiﬁcance of
stenosis, especially in patients with intermediate severity
stenosis [30].
Conclusions
Coronary CTA represents the only reliable noninvasive
alternative method to conventional selective coronary angi-
ography for coronary artery imaging. This diagnostic method
is especially useful in evaluation of subjects with suspected
CAD and low-to-intermediate pretest probability. The combi-
nation of coronary CTA with myocardial CTP or FFR-CT seems
to be promising.
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